Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-25-002176
Filing Date
2025-08-07
Accepted
2025-08-07 10:06:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9341
2 EX-99 20250807_183328004_13GFMR.txt EX-99 2837
  Complete submission text file 0000315066-25-002176.txt   14061
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000

Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Subject) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91164 | Film No.: 251192200
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)